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BtuCD is an ABC transporter catalyzing the uptake of vitamin B12 across the Escherichia coli inner
membrane. A previously reported X-ray structure of BtuCD in complex with the periplasmic vitamin
B12-binding protein BtuF revealed asymmetry of the transmembrane BtuC subunits. The functional
relevance of this asymmetry has remained uncertain. Here we report the X-ray structure of a cata-
lytically impaired BtuCD mutant in complex with BtuF, where the BtuC subunits adopt a distinct
asymmetric conformation. The structure suggests that BtuF does not discriminate between, or
impose, asymmetric conformations of BtuCD. It also explains the conformational disorder observed
in BtuCDF crystals.
Structured summary of protein interactions:
BtuF, BtuD and BtuC physically interact by X-ray crystallography (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In bacteria, binding protein-dependent ABC transporters
facilitate the uptake of diverse nutrients into the cytoplasm. The
Escherichia coli transporter BtuCD (Fig. 1A) catalyzes uptake of
vitamin B12, which is scavenged in the periplasm by the binding
protein BtuF [1,2]. Due to its architecture and mechanism, BtuCDF
belongs to the type II ABC importers; for reviews, see [3,4]. Two
X-ray structures have been reported: the structure of transporter
by itself was determined in an outward-facing conformation [5],
whereas that of the transporter-binding protein complex BtuCDF
(wt-BtuCDF; pdb ID: 2QI9) featured a closed asymmetric conforma-
tion [6]. While the former state represents the transporter poised to
accept its substrate from the binding protein, the latter corresponds
to a post-translocation state, i.e. after the B12 molecule has passed
through the translocation pathway and has been released into the
cytoplasm. In both structures, the cytosolic subunits (nucleotide
binding domains or NBDs) were found to be nucleotide-free.
ABC transporters undergo large conformational changes during
their transport cycles. In recent years, differences between ABC
importers of type I [7–9] and II [10,11] and ABC exporters [12–
14] have become evident. Therefore, it is essential to trap thechemical Societies. Published by E
cular Biology and Biophysics,
d. Fax: +41 44 633 1182.
er).
The University of Queensland,transporters in all states of the transport reaction, and to visualize
the relevant conformations at high resolution. In an effort to solve
the structure of a nucleotide-bound state of BtuCDF, we con-
structed a mutant that is able to bind, but incapable of hydrolyzing,
ATP. Despite the presence of nucleotide in the crystallization
setups, we unexpectedly trapped the complex BtuCDF in a
nucleotide-free state. However, compared to the previous BtuCDF
structure, an opposite asymmetry is now observed. This observa-
tion has important consequences for formulating a mechanism of
B12 transport through BtuCDF, as it suggests that BtuF does not
impose speciﬁc asymmetry in the post-translocation state.
2. Materials and methods
2.1. Molecular cloning
The mutation of BtuD (E159Q) was introduced into the cys-less
wild-type BtuCD plasmid (wt-BtuCD [6]) by standard PCR proce-
dures. A construct for expression of the C-terminally 6xHis tagged
BtuF (including OmpA signal peptide sequence) was produced
using standard molecular cloning techniques.
2.2. Protein expression
E. coli BL21(DE3) RIPL cells (Stratagene) were transformed with
plasmids encoding either wt-BtuCD, EQ-BtuCD, or BtuF. Cells were
grown in TB medium in 5 L bafﬂed ﬂasks to OD600 of 3 (or 0.8 inlsevier B.V. All rights reserved.
Fig. 1. Functional characterization of the BtuCDF complex with E159Q mutation. (A) Illustration of the architecture of wt- and EQ-BtuCDF. Letters ‘‘C’’, ‘‘D’’ and ‘‘F’’ indicate
BtuC, BtuD and BtuF, respectively; Q159 residue in BtuD is shown to affect the ATPase rate. (B) ATPase activity of wt-BtuCDF and EQ-BtuCDF. (C and D) ATP binding to wt-
BtuCDF was assessed using ATP-agarose beads; ‘T’ – total protein, ‘A’ – in the presence of 1 mM ATP, ‘N’ in the presence of 1 mM AMPPNP. The total volume of each assay was
60 ll, the volume of ATP-agarose slurry – 10 ll; ﬁnal protein concentration was 3 lM. Here and in subsequent ﬁgures, the labels ‘wt’ and ‘E159Q’ indicate wild type and
mutated BtuCDF complexes, respectively.
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IPTG. After 1.5 h at 37 C (4 h at 25 C for BtuF) cells were harvested
by centrifugation (8500 RPM, SLC-6000 rotor, 10 min, 4 C). Pel-
lets were stored at 80 C.
2.3. Protein puriﬁcation
For BtuF puriﬁcation, frozen cell pellets were resuspended in
50 mM Tris–HCl, pH 7.5, 200 mM NaCl, 10% glycerol, 25 mM imid-
azole and sonicated on ice. Protein was puriﬁed using a standard
Ni–NTA protocol and used directly for BtuCDF complex formation.
Frozen pellets of cells expressing wt-BtuCD or EQ-BtuCD were
resuspended in solubilization buffer (50 mM Tris–HCl, pH 7.5,
500 mM NaCl, 25 mM imidazole and 1% LDAO) and sonicated on
ice. The cell suspensions were stirred for 1.5 h and cell debris was
removed by centrifugation (16500 RPM, SLA-600 rotor, 30 min,
4 C). The supernatant was loaded onto Ni–NTA Superﬂow resin
(Qiagen), and the column was washed with solubilization buffer,
except that the concentration of LDAOwas 0.1%. After an additional
wash with 50 mM imidazole, the protein was eluted with 200 mM
imidazole. The concentration of imidazole in the eluted volumewas
adjusted to 25 mM by dilution and puriﬁed BtuF was added in a
1:3 M ratio before re-loading BtuCD onto a Ni–NTA superﬂow col-
umn. The detergent was then exchanged to 0.01% C12E8 using 10
column volumes of C12E8-containing wash buffer. Protein eluted
from Ni–NTA was concentrated and loaded onto a Superdex-200
10/300 GL gel ﬁltration columnpre-equilibrated in a buffer contain-
ing 10 mM Tris–HCl, pH 7.5, 100 mM NaCl, 0.5 mM ETDA, 0.01%
C12E8. The peak corresponding to BtuCDF complex was collected
and the presence of all three proteins was conﬁrmed by SDS PAGE.
2.4. ATP-agarose binding assay
Binding of ATP to wt-BtuCDF or the E159Q mutant was assessed
using ATP agarose (Jena Bioscience). Puriﬁed protein samples(3 lM BtuCD puriﬁed in LDAO, supplied with a twofold molar ex-
cess of BtuF) were incubated with 10 ll ATP-agarose slurry (60 ll
total volume) for 30 min on ice in 10 mM Tris, pH 7.5, 500 mM
NaCl, 5 mM MgCl2 and 0.1% LDAO, in the absence or in the pres-
ence of 1 mM ATP or AMPPNP; experiments at low pH were per-
formed in the presence of 100 mM Na-citrate, pH 5.4. Following
a short spin at 500 g using a cooling bench-top centrifuge, the
supernatants were removed and the beads washed once with
100 ll buffer containing the corresponding competitor (i.e., ATP,
AMPPNP or none). Samples of total reaction mixes, supernatants
and beads were analyzed using SDS PAGE (15%, Tris–Glycine).
Nucleotide binding was assessed by comparing the fraction of pro-
tein that remained bound on the ATP-agarose to the fraction of
protein that was in the supernatant (labeled as ‘‘Bound’’ and
‘‘Free’’, respectively).
2.5. ATPase activity assay
The ATP hydrolysis rate of the puriﬁed proteins was determined
by quantitating inorganic phosphate using a modiﬁed molybdate
method [15]. The protein concentration used in the assay was
0.02 mg/ml (0.1–1.26 mg/ml for EQ-BtuCDF), the concentrations
of ATP and MgCl2 were 1 mM and 5 mM, respectively. The assays
were performed at 22 C in triplicate and analyzed using linear
regression to compare hydrolysis rates.
2.6. Protein crystallization
For crystallization of EQ-BtuCDF the puriﬁed protein complex
was concentrated to 20 mg/ml and supplemented with 1 mM
AMPPNP and 5 mM MgCl2. Crystallizations trials were performed
by vapor diffusion in sitting drops using MRC-96 and Cryschem
plates. The initial crystals were obtained using in-house screens,
followed by custom optimization screens. Crystals of sufﬁcient size
for X-ray analysis were obtained in 100 mM sodium citrate, pH 5.4,
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tals were harvested and ﬂash frozen in liquid nitrogen.
2.7. Crystallization of BtuCD–SeMet–BtuF complex
Selenomethionine-labeled BtuF was produced using a proce-
dure described previously [6]. In brief, cells transfected with a plas-
mid encoding a 10xHis-tagged BtuF [6] were grown to an OD600 of
0.5 and supplemented with amino acids (L-lysine, L-threonine, L-
phenylalanine, L-methionine, L-isoleucine, L-leucine, L-valine at
200 lg/ml each, and 100 lg/ml of L-selenomethionine). After 1 h
of growth at 25 C, expression was induced by adding 0.4 mM IPTG.
Following a 4 h period, cells were collected and frozen. SeMet-BtuF
puriﬁcation and BtuCDF complex formation was performed
according to the procedure for non-labeled complex. Crystals ap-
peared in the presence of 30–38% PEG-400, 50 mM Tris–HCl, pH
8.4 or Glycine-NaOH, pH 9.4 and 400 mM ammonium sulfate.
2.8. X-ray data collection and structure determination
X-ray diffraction data were collected at the beamline X06SA at
Swiss Light Source, Villigen, Switzerland. Due to the delicate nature
and small dimensions of the crystals, data for EQ-BtuCDF were col-
lected using the microdiffractometer setup (15 lm beam size) and
in 0.5 wedges. For wt-BtuCDFSeMet crystals, the high-resolution
station of X06SA was used. Data processing was performed using
Denzo and Scalepack (HKL Research, Inc.). Phasing by molecular
replacement and the following reﬁnement steps were performed
using Phenix [16], and model building was performed using Coot
[17]. Selenium positions were found using three-wavelength
MAD phasing, and reﬁned using Sharp (Global Phasing Limited).
Coordinates and structure factors of EQ-BtuCDF were deposited
with the protein data bank (www.rcsb.org/pdb) under 4DBL.
3. Results
For our studies, the catalytically essential glutamate (E159) of
the Walker-B motif of BtuD was exchanged to a glutamine (EQ-
BtuCDF). Similar mutations have been used in other ABC systems
to study hydrolysis-deﬁcient NBDs [9,18,19]. The mutant E159Q
resulted in abolished ATP hydrolysis activity of BtuCDF, as shown
in Fig. 1B. The rate of ATP hydrolysis dropped by >1000-fold, from
387 ± 8.39 nmol/mg protein/min (n = 4) for wt-BtuCDF to
0.32 + 0.04 nmol/mg protein/min (n = 3) for the mutant. EQ-
BtuCDF was still able to bind nucleotides (and of course the
binding protein BtuF) in a manner similar to the wild-type proteinTable 1
Crystallographic reﬁnement statistics.
Data collection
Space group: P21
Cell dimensions (Å):
a = 133.65 b = 166.93 c = 132.82
a = 90.000 b = 119.76 c = 90.000
Resolution: 30–3.5
Number of reﬂections: 59380
Rsym or Rmerge (in highest resolution shell): 0.171 (0.719)
I/rI (in highest resolution shell): 9.728 (1.957)
Redundancy: 5.6
Completeness, %: 93.3
Reﬁnement
Resolution: 30–3.5
Rwork/Rfree: 0.2140/0.2513
Number of atoms: 21232
B-factors (Å2): 66.5
Bond length r.m.s.d. (Å): 0.004
Bond angle r.m.s.d. (): 0.784(Fig. 1C and D), conﬁrming that the mutation affected only the
hydrolysis rate.
We crystallized the EQ-BtuCDF complex in the presence of
AMPPNP, a non-hydrolyzable ATP analog and at pH 5.4. Crystals
were small and a micro-diffractometer setup at the synchrotron
was required to measure X-ray diffraction data. A molecular
replacement solution was quickly found using 2QI9 as a search
model and the structure was reﬁned to 3.5 Å resolution (Table 1).
The packing was distinct to that of the previously published wt-
BtuCDF structure [6], with two full EQ-BtuCDF complexes in the
asymmetric unit (Fig. 2A and B). Contrary to our expectations,
inspection of the electron density map revealed the absence of
bound nucleotide at either one of the NBDs (Fig. 2C). This could
be rationalized by the fact that at the pH/buffer condition used
for crystallization (Na-citrate, pH 5.4), the afﬁnity for nucleotide
is low (Fig. 2D; binding to ATP-agarose at low pH is only marginally
inhibited by the presence of ATP), whereas it is high at pH close to
physiological (Fig. 1). We conclude that despite excess AMPPNP in
the crystallization solution, nucleotide-free EQ-BtuCDF complex
crystallized more efﬁciently than nucleotide-bound complex.
Despite the absence of bound AMPPNP, an unexpected and strik-
ing feature was revealed: a comparison with 2QI9 revealed that
while the BtuC subunits (TMDs) were also asymmetrical in EQ-
BtuCDF, the orientation of BtuF relative to the BtuC dimer was ro-
tated by 180 (Fig. 3). If BtuF is used as an anchor of the superposi-
tion, the asymmetrical BtuC subunits of BtuCDF and EQ-BtuCDF
appear to have swapped places (Fig. 3B, C, E and F). This is best seen
by observing the loop connecting TM4 and TM5: In the EQ-BtuCDF
structure, this points in the opposite direction than in wt-BtuCDF.
To conﬁrm that this inversion of the BtuF orientation (or swap-
ping of BtuC conformation) is not an artefact due to the E159Q
mutation, we analysed X-ray diffraction data obtained from crystals
of wt-BtuCDF, where BtuF contained selenomethionine instead of
methionine. BtuF contains two coremethionines (M69,M105), both
located in the same, N-terminal lobe of the protein (Fig. 4A). How-
ever, most wt-BtuCDF crystals showed four instead of two selenium
peaks in the anomalous electron density maps (Fig. 4B), suggesting
that even for wt-BtuCD, both orientations of BtuF are possible in the
complex, although depending on the crystal, the intensity of the
pairs of peaks was not identical (not shown). The previously pub-
lished 2.6 Å resolution structure of wt-BtuCDF (2QI9) had been
solved as a result of identifying a single crystal that suffered only
to a small amount from this problem – still, only rigid body place-
ment of BtuF had been possible [6]. For EQ-BtuCDF, we assume that
the altered BtuF construct (C-terminal His-tag) and the distinct
lattice contacts in the crystals grown at lower pH facilitated the
crystallization of a single, asymmetric conformation. As a conse-
quence, the EQ-BtuCDF structure features a better quality density
for BtuF than the earlier wt-BtuCDF structure. Despite the modest
resolution of 3.5 Å, our current study therefore represents the most
complete view of the BtuCDF complex to date.
4. Discussion
Ever since the structure of the BtuCDF complex was reported
[6], the relevance of the observed asymmetric conformations in
the chemically identical BtuC subunits was something of an enig-
ma. Given that BtuF is an asymmetric molecule, it was speculated
that its two lobes (N- and C-lobe) interact with the two BtuC sub-
units differently, resulting in the observed asymmetry. Our struc-
ture establishes that this is not the case. BtuF does not seem to
impose, or discriminate between, the two asymmetric BtuC confor-
mations. We conclude that the BtuC subunits may adopt either of
the two asymmetric conformations in the nucleotide-free BtuCDF
complex. Once either asymmetric conformation is adopted, the
probability of switching to the other one is very low, as suggested
Fig. 2. X-ray structure of EQ-BtuCDF at low pH. (A and B) Protein packing in the crystals with space group P21. (C) Electron density maps reveal the absence of nucleotide in
the binding pocket. (D) ATP-agarose binding at pH 5.4 shows a weak competition of ATP with ATP-agarose for the nucleotide binding site of BtuCDF. The binding of protein to
agarose beads was performed as described under ‘‘Materials and methods’’ and in Fig. 1B.
Fig. 3. Comparison of wt- and EQ-BtuCDF structures, with BtuF used as anchor for superpositions. (A) Views of wt-BtuCDF [6], within the plane of a membrane. (B) A 12-Å
cross-section through the structure shows the asymmetrical arrangement of the gating helices TM4 and TM5 of the two BtuC subunits. (C) View from the cytoplasmic side of
the membrane. BtuC loops connecting TM4 and TM5 are colored orange. Arrows indicate the position of TM4–TM5 hairpin positioned asymmetrically in each structure. (D–F)
Structure of EQ-BtuCDF, with identical views as in A–C.
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Fig. 4. Two asymmetric states in wt-BtuCDF crystals. (A) Overview of the structure; Positions of the BtuF residues M69 and M105 are indicated by green circles. (B) Ca-traces
of BtuCD and BtuF are shown in yellow and red, respectively. Anomalous difference maps (green mesh: 3.5r, white mesh: 6r) of most wt-BtuCDFSeMet crystals revealed four
peaks, suggesting two orientations of BtuF. Inset: Anomalous difference maps of single wt-BtuCDFSeMet crystal used for structure determination of 2QI9, ﬁgure from [6].
976 V.M. Korkhov et al. / FEBS Letters 586 (2012) 972–976by EPR studies [20,21]. The translocation pathway for B12 is closed
in both conformations. This probably ensures that no continuous
channel is formed as the transporter reverts to the outward-facing
conformation and BtuF dissociates from BtuCD.
The described situation is not limited to BtuCDF, as there are
manyABC transporters, and indeedmany unrelatedmembrane pro-
teins, that feature asymmetric proteins interacting with a symmet-
ric multimer of protein subunits (e.g. toxins binding to ion channels
[22] or F1–F0 subunit interactions in ATP synthase [23]). However,
BtuCDF is to our knowledge the ﬁrst of thesemembrane proteins for
which distinct asymmetric conformations were revealed by crystal
structures. We expect that other type II ABC importers with two
identical TMDs, including those facilitating iron uptake into Gram-
negative pathogens [24], adopt similarly ambiguous conformations
when in complex with their cognate binding proteins. Our observa-
tion may thus be of general relevance.
In conclusion, the existing evidence suggests that BtuCDF may
adopt either of two asymmetric states revealed by X-ray struc-
tures. Both conformations represent post-translocation states of
BtuCDF, after B12 was released to the cytoplasm and before BtuF
dissociates from BtuCD. Efforts are now underway to structurally
characterize the nucleotide-bound states.
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